GSK · Categories · Upgrades

GSK - Analyst upgrades

GSK plc (GSK) analyst upgrades - real-time wire coverage filtered to Upgrades only.

Recent Upgrades for GSK

• 209d
  GlaxoSmithKline upgraded by BofA Securities

  BofA Securities upgraded GlaxoSmithKline from Underperform to Neutral
• 840d
  GlaxoSmithKline upgraded by Guggenheim

  Guggenheim upgraded GlaxoSmithKline from Neutral to Buy
• 860d
  GlaxoSmithKline upgraded by Citigroup

  Citigroup upgraded GlaxoSmithKline from Neutral to Buy
• 901d
  GlaxoSmithKline upgraded by Jefferies with a new price target

  Jefferies upgraded GlaxoSmithKline from Hold to Buy and set a new price target of $48.00
• 1193d
  GlaxoSmithKline upgraded by Deutsche Bank

  Deutsche Bank upgraded GlaxoSmithKline from Hold to Buy
• 1376d
  GlaxoSmithKline upgraded by Credit Suisse

  Credit Suisse upgraded GlaxoSmithKline from Underperform to Neutral
• 1690d
  GlaxoSmithKline upgraded by Barclays

  Barclays upgraded GlaxoSmithKline from Underweight to Equal-Weight
• 1824d
  GlaxoSmithKline upgraded by Deutsche Bank

  Deutsche Bank upgraded GlaxoSmithKline from Sell to Hold

Other GSK categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings